Vaccine stocks, if viewed as cyclical stocks, then the trend is downward; the stock price peaked before performance, which is also in line with the speculation rhythm of cyclical stocks;
The repetition of the epidemic can only be described as stimulating the market and causing vaccine stocks to rebound; after the bounce, they continued to decline. However, at this point, I don't really understand. If the market is falling, that's fine; excluding the downward trend brought about by factors such as interest rate hikes in the general market, there is currently a certain divergence in technology.
Not easy to operate, look $Moderna (MRNA.US)$Whether 140 can be maintained, the dosage can change
$Novavax (NVAX.US)$